By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Atara Biotherapeutics 

2659 Townsgate Road
Suite 236
Thousand Oaks  California  91361  U.S.A.
Phone: 805-309-0888 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Atara Biotherapeutics (ATRA) Doses First Patient In Phase 1 Clinical Study Of STM 434, An Activin Inhibitor 10/22/2014 7:15:43 AM
Nasdaq Welcomes Atara Biotherapeutics (ATRA) To The Nasdaq Stock Market 10/16/2014 10:38:54 AM
Atara Biotherapeutics (ATRA) To Ring The Nasdaq Stock Market Opening Bell In Celebration Of IPO 10/16/2014 7:37:06 AM
Atara Biotherapeutics (ATRA) Prices IPO Below The Range At $11 A Share 10/16/2014 7:34:51 AM
Atara Biotherapeutics Announces Immunotherapy Alliance With Memorial Sloan-Kettering Cancer Center 9/23/2014 9:08:10 AM
SoCal's Atara Biotherapeutics IPO Delayed By New Test Results 7/24/2014 7:55:23 AM
Amgen (AMGN) Spinoff Atara Biotherapeutics Hikes IPO Target From $50 Million To $92 Million 7/11/2014 8:16:49 AM
Atara Biotherapeutics Strengthens Board And Senior Management Team 4/8/2014 7:37:26 AM
Amgen (AMGN)'s Bay Area Spinoff, Atara Biotherapeutics, Hauls In $52 Million Series B Financing 1/10/2014 6:24:56 AM
//-->